Both in Pharmaceuticals
MapLight Therapeutics vs Neurogene
Over the past year MPLT returned −44.7% and NGNE returned −11.4%; their daily moves had a correlation of 0.14.
MPLT −44.7% NGNE −11.4%Growth of $1, one year, split-adjusted
| Metric | MPLT | NGNE |
|---|---|---|
| Price | $10.15 | $28.39 |
| Market cap | $564.1M | $568.1M |
| Today | −2.87% | −0.32% |
| 1 month | −19.4% | −22.4% |
| 6 months | −45.8% | +47.1% |
| Year to date | −42.2% | +37.8% |
| 1 year | — | +59.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $304.7M | $225.4M |
| Dividend yield | — | — |
| Volatility (60d) | 279.3% | 66.6% |
| Short % of float | 24.4% | 25.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).